GlassScriptPhysician profile
Jimmy Wyatt
NPI 1578550257
$4,032.66
in general payments reported to CMS, 2019-2025
22 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,306 · 2022: $1,367 · 2023: $654 · 2024: $508 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $823.82 | 2021-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $769.18 | 2021-2024 | Lux-Dx Insertable Cardiac Monitor, Ingevity+, Ingevity Mri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $435.76 | 2021-2023 | Jardiance |
| Abbott Laboratories | $266.60 | 2021-2024 | Jot Dx, Ensite, Aveir |
| Novartis Pharmaceuticals Corporation | $237.12 | 2021-2023 | |
| United Therapeutics Corporation | $230.85 | 2023-2024 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $220.21 | 2021-2024 | Wainua |
| Pfizer INC. | $151.66 | 2021-2022 | |
| Cvrx, INC. | $147.10 | 2023-2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $141.75 | 2021-2022 | |
| Medtronic, INC. | $108.71 | 2022-2024 | Symplicity G3, Launcher |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.92 | 2023-2025 | Lifevest |
| Inari Medical, INC. | $81.33 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Neurocrine Biosciences, INC. | $78.09 | 2022 | |
| Esperion Therapeutics, INC. | $76.73 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $71.74 | 2022 | |
| Cardiovascular Systems INC. | $22.87 | 2022 | |
| Angiodynamics, INC. | $16.63 | 2021 | |
| Amgen INC. | $16.59 | 2021 | |
| Irhythm Technologies, INC. | $16.24 | 2024 | Zio Monitor, Zio Xt Patch |
| Novo Nordisk INC | $14.88 | 2025 | |
| Kestra Medical Technology Services, INC. | $14.88 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Wyatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.